Title |
Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes
|
---|---|
Published in |
Frontiers in Cardiovascular Medicine, July 2018
|
DOI | 10.3389/fcvm.2018.00088 |
Pubmed ID | |
Authors |
Luigi Biasco, Enrico Ferrari, Giovanni Pedrazzini, Francesco Faletra, Tiziano Moccetti, Francesco Petracca, Marco Moccetti |
Abstract |
During the last ten years, transcatheter aortic valve implantation (TAVI) has become a reliable and valid alternative treatment for elderly patients with severe symptomatic aortic valve stenosis requiring valve replacement and being at high or intermediate surgical risk. While common femoral arteries are the access site of choice in the vast majority of TAVI patients, in up to 15-20% of TAVI candidates this route might be precluded due to the presence of diffuse atherosclerotic disease, tortuosity or small vessel diameter. Therefore, in order to achieve an antegrade or retrograde implant, several alterative access routes have been described, namely trans-axillary, trans-aortic, trans-apical, trans-carotid, trans-septal, and trans-caval. The aim of this paper is to give a concise overview on vascular access sites for TAVI, with a particular focus on patient's selection criteria, imaging, technical aspects, and clinical outcome. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 98 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 14 | 14% |
Student > Doctoral Student | 14 | 14% |
Student > Ph. D. Student | 9 | 9% |
Student > Postgraduate | 8 | 8% |
Student > Master | 7 | 7% |
Other | 16 | 16% |
Unknown | 30 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 50 | 51% |
Engineering | 6 | 6% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Nursing and Health Professions | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 0 | 0% |
Unknown | 34 | 35% |